Medius Holdings Co (TSE:3154) EBIT: 円616 Mil (TTM As of Dec. 2025)


TSE:3154 Medius Holdings Co Ltd TSE:3154
62 GF Score
Price 円789.00
GF Value 円998.62
Valuation Modestly Undervalued
! 7 Warning Signs
View Full Analysis

What is Medius Holdings Co EBIT?

Medius Holdings Co TSE:3154 -5.17% 62 EBIT is 円616 Mil as of Dec. 2025. GuruFocus rates TSE:3154 with a GF Score™ of 62/100 and a GF Value™ of 円998.62 (Modestly Undervalued). The stock has 7 warning signs investors should review.

Medius Holdings Co's earnings before interest and taxes (EBIT) for the three months ended in Dec. 2025 was 円0 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2025 was 円616 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Medius Holdings Co's annualized ROC % for the quarter that ended in Dec. 2025 was 0.00%. Medius Holdings Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 0.00%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Medius Holdings Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 2.34%.


Medius Holdings Co  (TSE:3154) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Medius Holdings Co's annualized ROC % for the quarter that ended in Dec. 2025 is calculated as:

ROC % (Q: Dec. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2025 ) + Invested Capital (Q: Dec. 2025 ))/ count )
=0 * ( 1 - 0% )/( (44558.109 + 51641.259)/ 2 )
=0/48099.684
=0.00 %

where

Invested Capital(Q: Jun. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=113024.98 - 60793.273 - ( 14371.034 - max(0, 81379.281 - 89052.879+14371.034))
=44558.109

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=127639.011 - 68323.536 - ( 19249.684 - max(0, 96692.839 - 104367.055+19249.684))
=51641.259

Note: The Operating Income data used here is four times the quarterly (Dec. 2025) data.

2. Joel Greenblatt's definition of Return on Capital:

Medius Holdings Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2025 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2025  Q: Dec. 2025
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=0/( ( (13100.283 + max(7324.732, 0)) + (12944.233 + max(13244.935, 0)) )/ 2 )
=0/( ( 20425.015 + 26189.168 )/ 2 )
=0/23307.0915
=0.00 %

where Working Capital is:

Working Capital(Q: Jun. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(57988.85 + 13611.83 + 339.33500000001) - (60793.273 + 0 + 3822.01)
=7324.732

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(66158.527 + 14997.461 + 3961.383) - (68323.536 + 0 + 3548.9)
=13244.935

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Dec. 2025) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Medius Holdings Co's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Dec. 2025 )
=616.182/26365.626
=2.34 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medius Holdings Co EBIT Related Terms


Medius Holdings Co EBIT Historical Data

* Premium members only.

The historical data trend for Medius Holdings Co's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medius Holdings Co EBIT Chart

Medius Holdings Co Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3,231.92 2,635.86 2,603.74 2,046.09 2,565.47

Medius Holdings Co Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25 Dec25 Mar26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 2,550.13 -1,042.77 0.00 1,658.96

TSE:3154 vs ISRG, BDX, MDLN: EBIT Comparison

For the Medical Instruments & Supplies subindustry, Medius Holdings Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medius Holdings Co EV-to-EBIT vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Medius Holdings Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Medius Holdings Co's EV-to-EBIT falls into.


TSE:3154
62GF Score
Medius Holdings Co Ltd TSE:3154
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medius Holdings Co EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was 円616 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of 円616 Mil mean?
Medius Holdings Co (TSE:3154) has a EBIT of 円616 Mil as of Dec. 2025. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Medius Holdings Co.
Is Medius Holdings Co's EBIT too high?
Medius Holdings Co's current EBIT is 円616 Mil. Overall, Medius Holdings Co has a GF Score™ of 62/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medius Holdings Co's EBIT compare to ISRG and BDX?
Medius Holdings Co's EBIT of 円616 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Medical Devices & Instruments company?
A good EBIT depends on the Medical Devices & Instruments industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Medius Holdings Co. Medius Holdings Co's current EBIT is 円616 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medius Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, Medius Holdings Co (TSE:3154) is currently considered Modestly Undervalued. The stock's GF Value™ is 円998.62, compared to a current price of 円789.00 — trading 21% below its estimated fair value. The current EBIT is 円616 Mil. Medius Holdings Co's overall GF Score™ is 62/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Medius Holdings Co (TSE:3154), the current EBIT is 円616 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medius Holdings Co (TSE:3154) Overvalued in 2026?

Based on GuruFocus' analysis, Medius Holdings Co stock appears to be undervalued. The current stock price of 円789.00 is trading 21% below its estimated GF Value™ of 円998.62. GuruFocus considers Medius Holdings Co to be Modestly Undervalued.

Key valuation signals for TSE:3154:

  • EBIT: 円616 Mil
  • GF Value™: 円998.62 vs. price of 円789.00 (21% below fair value)
  • GF Score™: 62/100 with 7 warning signs

No single metric tells the full story. See the TSE:3154 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Medius Holdings Co Business Description

Address 1-2-2 Yurakucho, Chiyoda-ku, Tokyo, JPN, 104-0031
Medius Holdings Co Ltd is engaged in the healthcare sector. The company's business division includes Medical equipment sales business, Care and welfare business, and Solution business. The Medical equipment sales business offers syringes and gloves to surgical assistance along with repairs and maintenance of medical equipment, and The care and welfare business provides transfer equipment and electric powdered beds. The company's segments include: Medical equipment sales business; and Nursing care and welfare business. It derives maximum revenue from Medical equipment sales business.
62GF Score

Get the complete analysis for TSE:3154

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円789.00
Price
円998.62
GF Value